Mnemosyne Pharmaceuticals Secures $6,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Mnemosyne Pharmaceuticals
  • Mailing Address
    One Davol Square Providence, RI 02903
  • Company Description
    The company is a Providence-based drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
  • M&A Terms
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Clal Biotechnology Industries Ltd.

Trending on Xconomy